In addition, ACLS4 was previously proposed as a candidate gene associated with metabolic syndrome (MetS), and the common single nucleotide polymorphism (C to T substitution in the first intron) of ACSL4 unfavorably alters the fatty acyl profiles of plasma phosphatidylcholines (PCs) in MetS patients [33]. The gene discussed is ACSL4; the disease is metabolic syndrome.